Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
01 6Bal Pharma
02 4Aucta Pharmaceuticals
03 3Pharmathen SA
04 3ABC Farmaceutici SpA
05 3Abdi Ibrahim
06 9Accord healthcare
07 6Actavis Inc
08 6Alembic Pharmaceuticals Limited
09 9Alkem Laboratories
10 18Alphapharm PTY Ltd
11 3Amneal Pharmaceuticals
12 6Annora Pharma
13 6Apotex Inc
14 18Arrotex Pharmaceuticals
15 6Ascent Innovative Medicines
16 3Auro Pharma Inc
17 6Aurobindo Pharma Limited
18 1Avenza Pharmaceuticals
19 3Bionpharma
20 3CHEMO
21 3Chartwell Pharmaceuticals llc
22 6Cipla
23 3DOC Generici
24 3Farmatek
25 3GLENMARK SPECLT
26 3Inventia Healthcare Limited
27 3Jerome Stevens Pharmaceuticals
28 18Juno Pharmaceuticals Pty Ltd
29 4KMS Health Center
30 9MSN Laboratories
31 6Mepha Pharma
32 9NORVIUM BIOSCIENCE
33 18Novartis Pharmaceuticals Australia Pty Limited
34 24Novartis Pharmaceuticals Corporation
35 5Novartis South Africa (Pty) Ltd
36 36Pharmacore Inc
37 6Pharmascience Inc.
38 3Piramal Pharma Solutions
39 27Sandoz B2B
40 6Sun Pharmaceutical Industries Limited
41 6Taro Pharmaceutical Industries
42 18Teva Pharma Australia
43 9Teva Pharmaceutical Industries
44 9Torrent Pharmaceuticals Limited
45 3Viatris
46 4World Medicine
47 6Zentiva
48 6Zydus Pharmaceuticals
01 1DISPERSIBLE TABLET
02 3DISPERSIBLE TABLET
03 3DSP
04 3Dispersible Tablet
05 2FCT
06 6Film Coated Tablet
07 5Film-Coated Tablet
08 4Film-Coated Tablet Oral Use Blister
09 3Film-Coated Tablet Oral Use Pvc/Pvdc/Aluminium
10 18Film-Coated Tablets
11 6Filmtabl
12 27GRANULE;ORAL
13 6Lactab
14 1Oral Granule
15 3Oro Dispersible Tablet
16 21TABLET
17 15TABLET FOR SUSPENSION
18 36TABLET, FOR SUSPENSION;ORAL
19 45TABLET;ORAL
20 19Tablet
21 3Tablet for Oral Suspension
22 4Tablet for Oral suspension
23 144Blank
01 21DISCN
02 3EU Approved
03 11Generic
04 5Originator
05 87RX
06 251Blank
01 3APO-DEFERASIROX
02 3APO-DEFERASIROX (TYPE J)
03 3AURO-DEFERASIROX (TYPE J)
04 3DEFEJACT
05 99DEFERASIROX
06 3DEFERASIROX ABDI
07 3DEFERASIROX ACCORD
08 3DEFERASIROX AUROBINDO
09 3DEFERASIROX DOC
10 3DEFERASIROX MYLAN
11 3DEFERASIROX SANDOZ
12 3DEFERASIROX ZENTIVA
13 18DEFERASIROX-TEVA
14 3Deferasirox
15 18Deferasirox ARX
16 6Deferasirox Accord
17 3Deferasirox DT
18 18Deferasirox Juno
19 18Deferasirox Sandoz
20 6Deferasirox-Mepha
21 9EXJADE
22 18Eferas
23 3Exjade
24 6JADENU
25 3JADENU SPRINKLE
26 26Jadenu
27 3PMS-DEFERASIROX
28 3PMS-DEFERASIROX (TYPE J)
29 18Pharmacor Deferasirox
30 18Pharmacor Deferasirox FC
31 3SANDOZ DEFERASIROX
32 3SANDOZ DEFERASIROX (TYPE J)
33 3TARO-DEFERASIROX
34 3TARO-DEFERASIROX (TYPE J)
35 37Blank
01 144Australia
02 33Canada
03 3Czech Republic
04 3Greece
05 23India
06 24Italy
07 5South Africa
08 3Spain
09 18Switzerland
10 10Turkey
11 1U.S.A
12 108USA
13 3United Kingdom
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Deferasirox
Dosage Form : Tablet
Dosage Strength : 360MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Aucta is a global brand that creates better products from proven molecules.
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFERASIROX
Dosage Form : GRANULE;ORAL
Dosage Strength : 90MG
Packaging :
Approval Date : 2021-03-09
Application Number : 214559
Regulatory Info : RX
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Tablet
Dosage Strength : 90MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Deferasirox
Dosage Form : Tablet
Dosage Strength : 180MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Deferasirox
Dosage Form : Tablet
Dosage Strength : 90MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Deferasirox DT
Dosage Form : Tablet
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Deferasirox DT
Dosage Form : Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Deferasirox DT
Dosage Form : Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Aucta is a global brand that creates better products from proven molecules.
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFERASIROX
Dosage Form : GRANULE;ORAL
Dosage Strength : 180MG
Packaging :
Approval Date : 2021-03-09
Application Number : 214559
Regulatory Info : RX
Registration Country : USA
Aucta is a global brand that creates better products from proven molecules.
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFERASIROX
Dosage Form : GRANULE;ORAL
Dosage Strength : 360MG
Packaging :
Approval Date : 2021-03-09
Application Number : 214559
Regulatory Info : RX
Registration Country : USA
Aucta is a global brand that creates better products from proven molecules.
Regulatory Info :
Registration Country : U.S.A
Brand Name :
Dosage Form : Oral Granule
Dosage Strength : 360MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Tablet
Dosage Strength : 180MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Tablet
Dosage Strength : 360MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFERASIROX
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2016-01-26
Application Number : 203560
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFERASIROX
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2016-01-26
Application Number : 203560
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFERASIROX
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2016-01-26
Application Number : 203560
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Australia
Brand Name : Eferas
Dosage Form :
Dosage Strength :
Packaging : 30
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Deferasirox ARX
Dosage Form :
Dosage Strength :
Packaging : 30
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : RX
Registration Country : USA
Brand Name : EXJADE
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2005-11-02
Application Number : 21882
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EXJADE
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2005-11-02
Application Number : 21882
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EXJADE
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2005-11-02
Application Number : 21882
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Australia
Brand Name : Pharmacor Deferasirox FC
Dosage Form :
Dosage Strength :
Packaging : 30
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Deferasirox Sandoz
Dosage Form :
Dosage Strength :
Packaging : 30
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Deferasirox Sandoz
Dosage Form :
Dosage Strength :
Packaging : 30
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : DEFERASIROX-TEVA
Dosage Form :
Dosage Strength :
Packaging : 30
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : DEFERASIROX-TEVA
Dosage Form :
Dosage Strength :
Packaging : 30
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DEFERASIROX
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2024-05-17
Application Number : 206585
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DEFERASIROX
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2024-05-17
Application Number : 206585
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Australia
Brand Name : Jadenu
Dosage Form :
Dosage Strength :
Packaging : 30
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Australia
Brand Name : Jadenu
Dosage Form :
Dosage Strength :
Packaging : 30
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
